Trials / Unknown
UnknownNCT04591704
The Effect of Diabetes Mellitus on the Prognosis of Patients With COVID-19
The Effect of Diabetes Mellitus on the Morbidity and Mortality Rates in Patients With COVID-19
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Uşak University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- —
Summary
All hospitalised patients with COVID-19 who have positive RT-PCR for SARS-COV-2 will be included in the study. The patients will be divided into two groups, as diabetics and non-diabetics. The COVID-19 patients' medical records will be evaluated and compared in terms of the duration of hospitalization, the presence of lung involvement in Computerised Tomography, the need for intensive care unit and mortality rates in patients with and without diabetes.
Detailed description
All hospitalised patients with COVID-19 who have positive RT-PCR for SARS-COV-2 will be included in the study. The patients will be divided into two groups, as diabetics and non-diabetics. The diagnosis of diabetes mellitus will be extracted from the medical records and medical history of the patients hospitalised with COVID-19. The COVID-19 patients medical records will be evaluated and compared in terms of the duration of hospitalization, the presence of lung involvement in Computerised Tomography, the need for intensive care unit and mortality rates in patients with and without diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | hospitalisation, necessity of ICU, mortality rate, lung involvement | hospitalisation, necessity of ICU, mortality rate, lung involvement |
Timeline
- Start date
- 2020-03-20
- Primary completion
- 2020-10-15
- Completion
- 2021-07-01
- First posted
- 2020-10-19
- Last updated
- 2021-05-04
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT04591704. Inclusion in this directory is not an endorsement.